For more information about this clinical trial, please visit the following link: https://clinicaltrials.gov/study/NCT05774951
Clinical trials study type
Clinical trials trial status
IRB number
2058558
Principal investigator
Priyanka Mittar, DO
Clinical trials study number
Cambria-1 (G2306)
Clinical trials title (full)
Cambria-1: A Study of Camizestrant in ER+/​HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy